Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Strategic stockpile of medicines 2017.

  • First published: 01 July 2016
  • Last modified: 01 July 2016
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Commercial Medicines Unit
Authority ID:
AA26502
Publication date:
01 July 2016
Deadline date:
28 July 2016
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This procurement exercise is intended to establish a framework agreement against which Public Health England would call-off their requirements for the stockpile of emergency medicines. This includes the provision of: ciprofloxacin (tablets, suspension and injection), doxycycline and gentamicin. The duration of the framework agreement is 2 years with an option to extend for up to a further 2 years.

Full notice text

CONTRACT NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)


The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)

2nd Floor, Rutland House

Runcorn

WA7 2ES

UK

NUTS Code — UK

Nichols Lynne


lynne.nichols@dh.gsi.gov.uk


https://cmu.bravosolution.co.uk



https://cmu.bravosolution.co.uk
Checked box
Unchecked box
Checked box
Unchecked box
Checked box
Unchecked box

I.2)

Type of contracting Authority and Main Activity or Activities

Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
public procurement
Yes

Please refer to Section VI.3) Additional Information of this notice

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

Strategic stockpile of medicines 2017.

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

Checked box Unchecked box Unchecked box
Unchecked box Unchecked box

II.1.2(c))

Type of service contract

II.1.2)

Main site or location of works, place of delivery or performance

To a location in England to be notified to the successful bidder(s) following award to framework agreement.



UK

II.1.3)

This notice involves

Unchecked box
Unchecked box
Checked box

II.1.4)

Information on framework agreement (if applicable)

Unchecked box
Checked box

Number of participants to the framework agreement envisaged

Duration of the framework agreement

4

Justification for a framework agreement the duration of which exceeds four years

Estimated total value of purchases for the entire duration of the framework agreement

16 000 00041 000 000GBP

Frequency and value of the contracts to be awarded

II.1.5)

Short description of the contract or purchase(s)

This procurement exercise is intended to establish a framework agreement against which Public Health England would call-off their requirements for the stockpile of emergency medicines. This includes the provision of: ciprofloxacin (tablets, suspension and injection), doxycycline and gentamicin. The duration of the framework agreement is 2 years with an option to extend for up to a further 2 years.

II.1.6)

Common Procurement Vocabulary (CPV)

33600000
33651000
33690000

II.1.7)

Contract covered by the Government Procurement Agreement (GPA)

Checked box

II.1.8)

Division into lots

Yes

Unchecked box Checked box Unchecked box

II.1.9)

Will variants be accepted

No

II.2)

Quantity or Scope of the Contract

II.2.1)

Total quantity or scope

Each individual product description i.e. ciprofloxacin tablets, ciprofloxacin suspension, ciprofloxacin injection, doxycycline and gentamicin is deemed to be a separate lot for the application of the award criteria. There is no restriction on the number of lots that bidders can offer, or be awarded.

16 000 00041 000 000
GBP

II.2.2)

Options

This framework agreement has the option to be extended for a period of up to 24 months.

Provisional timetable for recourse to these options

Number of possible renewals

In the case of renewable supplies or service contracts, estimated time frame for subsequent contracts

II.3)

Duration of the contract or limit for completion

 1-4-2017 31-3-2021

Section III: Legal, Economic, Financial and Technical Information

III.1)

Conditions Relating to the Contract

III.1.1)

Deposits and guarantees required

Parent company or other guarantees may be required in certain circumstances.

Please refer to the PQQ evaluation approach document which can be accessed once you have expressed an interest within the Bravo portal under ‘Strategic stockpile of medicines 2017’.

III.1.2)

Main Terms of financing and payment and/or reference to the relevant provisions

Information will be contained within the Invitation to Offer.

III.1.3)

Legal form to be taken by the grouping of suppliers, contractors or service providers to whom the contract is to be awarded

No special legal form is required but, if a contract is awarded to a consortium of economic operators, the members of that consortium may be required to form a legal entity before entering into a Framework Agreement and may be required to provide parent company or directors' guarantees or, if not required to form a legal entity, members of a consortium may be required to accept joint and several liability both to the Contracting Authority under the Framework Agreement and to other contracting authorities awarding contracts under the Framework Agreement.

III.1.4)

Other particular conditions to which the performance of the contract is subject

Information will be contained within the Invitation to Offer.

III.2)

Conditions for Participation

III.2.1)

Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers


III.2.2)

Economic and financial capacity


Please refer to the selection criteria contained in the PQQ.




III.2.3)

Technical capacity


Please refer to the selection criteria contained in the PQQ.




III.2.4)

Reserved contracts

Unchecked box
Unchecked box

Section IV: Procedure

IV.1)

Type of Procedure


Unchecked box Checked box
Unchecked box Unchecked box
Unchecked box Unchecked box

Justification for the choice of accelerated procedure

IV.1.1)

Have candidates already been selected?

No

IV.1.2)

Limitations on the number of operators who will be invited to tender or to participate

Objective criteria for choosing the limited number of candidates

IV.1.3)

Reduction of the number of operators during the negotiation or dialogue

Unchecked box

IV.2)

Award Criteria

No


Yes

No

IV.2.2)

An electronic auction will be used

No

IV.3 Administrative Information

IV.3.1)

Reference number attributed to the notice by the contracting authority

CM/EMP/15/5471

IV.3.2)

Previous publication(s) concerning the same contract

Unchecked box
Unchecked box


Other previous publications

IV.3.3)

Conditions for obtaining specifications and additional documents



 


IV.3.4)

Time-limit for receipt of tenders or requests to participate

 28-07-2016  13:00

IV.3.5)

Date of dispatch of invitations to tender or to participate to selected candidates


IV.3.6)

Language or languages in which tenders or requests to participate can be drawn up

Checked box    

IV.3.7)

Minimum time frame during which the tenderer must maintain the tender 

IV.3.8)

Conditions for opening tenders



Commercial Medicines Unit Employee.



Section VI: Other Information

VI.1)

Indicate whether this procurement is a recurrent one and the Estimated timing for further notices to be published


VI.2)

Does the contract relate to a Project/Programme financed by Community Funds?

No



VI.3)

Additional Information

Any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information:

This procurement exercise will be conducted on the eTendering portal at: www.cmu.bravosolution.co.uk Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:

1.1) If not already registered, Candidates should register on the eTendering portal at: https://www.cmu.bravosolution.co.uk and click the link to register:

— Accept the terms and conditions and click continue,

— Enter your correct business and user details,

— Note the username you chose and click ‘Save’ when complete,

— You will shortly receive an email with your unique password (please keep this secure).

1.2) Once registered, candidates must express interest as follows:

a. Login to the eTendering portal;

b. Select ‘Response to PQQ’;

c. Select ‘PQQs Open to All Suppliers’;

d. Access listing related to this procurement ‘Strategic stockpile of medicines 2017’ and view details;

e. Click on ‘Express interest’ button at the top of the page;

f. Once you have expressed interest, the PQQ will move to ‘My PQQs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering help desk at. +44 800 368 4850 or: help@bravosolution.co.uk

2) General supplier information.

To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Governments supplier information database, sid4gov, as follows:

2.1) If not already registered, Candidates must go to the following web page: https://sid4gov.cabinetoffice.gov.uk/ and select ‘Register for sid4gov’ at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4gov.

2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning sid4gov, please contact the sid4gov help desk at: support@nqc.com or telephone. +44 (0) 845 299 2994.

Other Contracting Authorities:

The framework agreement is for the benefit of the Contracting Authority, NHS bodies and other public bodies responsible for delivery of health related services in the United Kingdom including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers, other government departments and non-department public bodies.

Where a framework agreement is concluded with a single economic operator, contracts based on that agreement shall be awarded within the limits of the terms laid down in the framework agreement.

For the award of those contracts, contracting authorities may consult the economic operator party to the framework agreement in writing, requesting it to supplement its tender as necessary.

Where a framework agreement is concluded with more than 1 economic operator, that framework agreement shall be performed by following the terms and conditions of the framework agreement, without reopening competition, where it sets out all the terms governing the provision of the works, services and supplies concerned and the objective conditions for determining which of the economic operators, party to the framework agreement, shall perform them; the latter conditions shall be indicated in the procurement documents for the framework agreement.

Electronic Ordering, Invoicing and/or Payment:

a) Electronic Submission of Tenders or requests to participate will be required;

b) Some participating authorities may use electronic ordering. Some participating authorities may accept electronic invoicing. Some participating authorities may use electronic payment.

Transparency:

Potential suppliers should note that, in accordance with the Government's policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: https://www.gov.uk/government/policies/buying-and-managing-government-goods-and-services-more-efficiently-and-effectively

VI.4)

Procedures for appeal

VI.4.1)

Body responsible for appeal procedures










Body responsible for mediation procedures










VI.4.2)

Lodging of appeals

VI.4.3)

Service from which information about the lodging of appeals may be obtained










VI.5)

Dispatch date of this Notice

 27-06-2016

ANNEX B

Information About Lots

   

1)

Short Description

2)

Common Procurement Vocabulary (CPV)

33600000

3)

Quantity or scope


4)

Indication about different contract dates

5)

Additional Information about lots

Each individual product description is deemed to be a separate lot for the application of the award criteria. There is no restriction on the number of lots that bidders can offer, or be awarded NUTS code for each lot is UK.


Coding

Commodity categories

ID Title Parent category
33651000 General anti-infectives for systemic use and vaccines General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products
33690000 Various medicinal products Pharmaceutical products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
lynne.nichols@dh.gsi.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.